If you need more lookups,
subscriptions start at $34 USD/month.
Jeff Kan Location
Boston, MA, US
Jeff Kan Work
Enginner III @ (October 2024 - Present)
Scientist @ (January 2024 - October 2024)
Principal Associate Scientist @ (January 2023 - January 2024)
Senior Associate Scientist @ (May 2021 - January 2023)
Senior Associate Scientist II Downstream Process Development @ (July 2020 - May 2021)
Senior Associate Scientist I Downstream Process Development @ (July 2019 - July 2020)
Contractor @ (May 2019 - July 2019)
Co-Op @ (May 2018 - May 2019)
Co-Op @ (May 2017 - January 2018)
Co-Op @ (September 2016 - December 2016)
Jeff Kan Education
Northeastern University
Bachelors of Science (Biochemistry)
2014-2019
Southridge High School
Recipient of International Baccalaureate Diploma
2010-2014
Jeff Kan Skills
AKTA
Affinity Chromatography
Apple Keynote
Apple Numbers
Apple Pages
Biochemistry
Biotechnology
Buffer Preparation
Chemistry, Manufacturing, and Controls (CMC)
Clarification
Data Analysis
Depth Filtration
Diafiltration
Downstream Processing
Droplet Digital PCR (ddPCR)
Drug Development
Fast Protein Liquid Chromatography (FPLC)
Gel Electrophoresis
Gene Therapy
Ion Chromatography
Leadership
Management
Microscopy
Microsoft Excel
Microsoft Office
Microsoft Word
Molecular Genetics
Nanofiltration
Organic Chemistry
PowerPoint
Process development
Protein Purification
Purification
TFF
Tangential Flow Filtration
Teaching
Technology Transfer
UF/DF
UFDF
UNICORN
Ultrafiltration
Ultratfiltration
Viral Clearance
Viral Filtration
Jeff Kan Summary
Jeff Kan, based in Boston, MA, US, is currently a Enginner III at Alexion Pharmaceuticals, Inc.. Jeff Kan brings experience from previous roles at Frontera Therapeutics and Solid Biosciences. Jeff Kan holds a 2014 - 2019 Bachelors of Science in Biochemistry @ Northeastern University. With a robust skill set that includes AKTA, Affinity Chromatography, Apple Keynote, Apple Numbers, Apple Pages and more. Jeff Kan has 3 emails on RocketReach.
Looking for a different Jeff Kan?
Find contact details for 700 million professionals.